Acitretin
14 NDCs across 5 manufacturers|14 Generic,0 Brand
Acitretin is used to treat psoriasis, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Oct 28, 1996, and the first generic was approved Apr 4, 2013. FDA's Orange Book lists 17 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $14 million on Acitretin across 45,000 claims for 10,000 beneficiaries.
Acitretin is available as 14 NDCs from 5 manufacturers (14 generic, 0 brand), with NADAC prices from $2.59 to $4.52 per EA — a 74% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
14
14G / 0B
Manufacturers
5
competing in market
Price Spread
$2.59 – $4.52
per EA
7d Activity
avg +3.2% WoW · of 14 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Amneal Pharmaceuticals of New York LLC manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Retinoid class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
5 manufacturers producing ACITRETIN(1 pricing outlier)
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
ACITRETIN 17.5 MG CAPSULE | $4.5184 per EA | -1.43% |
ACITRETIN 17.5 MG CAPSULE | $4.5184 per EA | -1.43% |
ACITRETIN 17.5 MG CAPSULE | $4.5184 per EA | -1.43% |
ACITRETIN 17.5 MG CAPSULE | $4.5184 per EA | -1.43% |
ACITRETIN 25 MG CAPSULE | $3.5423 per EA | -1.65% |
ACITRETIN 25 MG CAPSULE | $3.5423 per EA | -1.65% |
ACITRETIN 25 MG CAPSULE | $3.5423 per EA | -1.65% |
ACITRETIN 25 MG CAPSULE | $3.5423 per EA | -1.65% |
ACITRETIN 25 MG CAPSULE | $3.5423 per EA | -1.65% |
ACITRETIN 10 MG CAPSULE | $2.5946 per EA | +11.72% |
ACITRETIN 10 MG CAPSULE | $2.5946 per EA | +11.72% |
ACITRETIN 10 MG CAPSULE | $2.5946 per EA | +11.72% |
ACITRETIN 10 MG CAPSULE | $2.5946 per EA | +11.72% |
ACITRETIN 10 MG CAPSULE | $2.5946 per EA | +11.72% |
Frequently Asked Questions
What is Acitretin used to treat?
Acitretin is used to treat psoriasis, per the National Library of Medicine's MED-RT classification.
When did Acitretin become available as a generic?
FDA approved the first generic Acitretin (ANDA) on Apr 4, 2013. The Orange Book currently lists 17 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Acitretin?
In 2024, Medicare Part D spent $14 million on Acitretin across 45,000 claims for 10,000 beneficiaries.
How many Acitretin products are on the market?
The Acitretin drug market contains 14 NDCs from 5 manufacturers — 14 generic and 0 brand products.
What is the price range for Acitretin?
NADAC reference prices for Acitretin range from $2.5946 to $4.5184 per EA — a 74% difference between cheapest and most expensive.
Which manufacturers make Acitretin?
5 manufacturers list Acitretin in NADAC. Ranked by number of NDCs, the largest are Amneal Pharmaceuticals of New York LLC (3), Teva Pharmaceuticals USA Inc. (3), Sigmapharm Laboratories LLC (3), Alembic Pharmaceuticals Inc. (3), Mylan Pharmaceuticals Inc. (2).
How has the price of Acitretin changed recently?
Over the past 7 days, 5 Acitretin NDCs rose and 9 fell, with a market-wide average change of +3.2%.